Ribaldone DG, Tribocco E, Scaldaferri F, Murgiano M, et al. Clinical Outcomes After Ustekinumab Biosimilar Switching in Crohn's Disease: the USBIOS IG-IBD Study. Clin Gastroenterol Hepatol 2026 Aug 27:S1542-3565(26)00637.
PMID: 42660257